All

× UPDATE! Updated as of 24 May 2024.
Records 301 to 320 of 32652
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Classification
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View BR-1461 Ocrelizumab Ocrevus 300 mg/10 ml (30 mg/ml) oncentrate for Solution for Intravenous Infusion Prescription Drug (RX) - F. Hoffmann-La Roche Ltd. Switzerland Monitored Release 22 December 2023 22 December 2028
View BR-1462 Ocrelizumab Ocrevus 300 mg/10 ml (30 mg/ml) Concentrate for Solution for Intravenous Infusion. Prescription Drug (RX) - Roche Diagnostics GmbH Germany Monitored Release 22 December 2023 22 December 2028
View BR-1463 Trastuzumab Hertumab 150 mg Powder for Concentrate for Solution for Infusion. (IV) Prescription Drug (RX) - Shanghai Henlius Biopharmaceutical Co., Ltd. China Initial 04 January 2024 04 January 2029
View BR-1464 Trastuzumab deruxtecan Enhertu 100 mg Powder for Concentrate for Solution for Infusion (IV) Prescription (Rx) Drug - Baxter Oncology GmbH Germany Monitored Release 15 January 2024 15 January 2029
View BR-1465 Japanese Encephalitis Vaccine (Inactivated, Adsorbed) Jeev 6 mcg/0.5 mL Suspension for Injection (IM) Prescription Drug (RX) Vaccines Biological E. Limited India Monitored Release (MR) [Reapplication] 08 February 2024 08 February 2029
View BR-1466 Anifrolumab Saphnelo 300 mg/2 mL (150 mg/ml) Concentrate for Solution for Infusion (IV) Prescription Drug (RX) Monoclonal Antibody. AstraZeneca Nijmegen B.V. Netherlands Monitored Release 14 February 2024 14 February 2029
View BR-1467 Avelumab Bavencio 200 mg/10 mL (20 mg/mL) Concentrate for Solution for Infusion (IV) Prescription Drug (RX) Monoclonal Antibodies Merck Serono SA Switzerland Monitored Release (MR) 22 February 2024 22 February 2029
View BR-1468 Semaglutide Wegovy 0.25 mg/0.37 mL (0.68 mg/mL) Solution Injection (SC) Prescription Drug (RX) Glucagon-like peptide (GLP-1) Analogues Novo Nordisk A/S Denmark Monitored Release (MR) 28 February 2024 28 February 2029
View BR-1469 Semaglutide Wegovy 2.4 mg/ 0.75 mL (3.2 mg/mL) Solution for Injection (SC) Prescription Drug (Rx) Glucagon-like peptide (GLP-1) Analogues Novo Nordisk A/S Denmark Monitored Release (MR) 28 February 2024 28 February 2029
View BR-1470 Semaglutide Wegovy 0.5 mg/0.37 mL (1.34 mg/mL) Solution for Injection (SC) Prescription Drug (Rx) Glucagon-like peptide (GLP-1) Analogues Novo Nordisk A/S Denmark Monitored Release (MR) 28 February 2024 28 February 2029
View BR-1471 Semaglutide Wegovy 1 mg/0.75 mL (1.34 mg/mL) Solution for Injection (SC) Prescription Drug (RX) Glucagon-like peptide (GLP-1) Analogues. Novo Nordisk A/S Denmark Monitored Release (MR) 28 February 2024 28 February 2029
View BR-1472 Semaglutide Wegovy 1.7 mg/ 0.75 mL (2.27 mg/mL) Solution for Injection (SC) Prescription Drug (RX) Glucagon-like peptide (GLP-1) Analogues Novo Nordisk A/S Denmark Monitored Release (MR) 28 February 2024 28 February 2029
View BR-1478 Rituximab Rituxell 10 mg/mL Concentrate for Solution for Infusion (IV) Prescription Drug (RX) Monoclonal Antibodies Joint Stock Company Biocad Russia Initial 28 February 2024 28 February 2029
View BR-1479 Bevacizumab Bevalast 25 mg/mL Concentrate for Solution for Infusion (IV) Prescription Drug (RX) Monoclonal Antibodies Joint Stock Company Biocad Russia Initial 28 February 2024 28 February 2029
View BR-1480 Spesolimab Spevigo 450 mg/7.5 mL (60 mg/mL) Concentrate for Solution for Infusion (IV) Prescription (Rx) Drug Interleukin inhibitors Boehringer Ingelheim Pharma GmbH & Co. KG Germany Monitored Release (MR) 05 April 2024 05 April 2029
View BR-1481 Heparin Sodium Hepadur 1000 IU/mL Solution for Injection (IV) Prescription Drug (Rx) Antithrombotic agents Tianjin Biochemical Pharmaceutical Co., Ltd China Renewal 05 May 2024 19 May 2029
View BR-220 Rabbies Vaccine (Inactivated)(Wistar Strain Rabies) Verorab 2.5 IU/ 0.5 mL Powder For Suspension(ID/IM) Prescription Drug (RX) - Sanofi Pasteur, Inc. France Renewal 26 May 2023 10 December 2027
View BR-280 Typhoid Polysaccharide Vaccine Typhim Vi Formulation: Each dose (0.5 mL) contains: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain)...................... 25 mcg Solution for Injection (IM/SC) Prescription Drug (RX) - Sanofi Pasteur France - 18 March 2022 01 March 2027
View BR-289 Rabbit Anti-Human Thymocyte Immunoglobulin Thymoglobuline 5 mg/mL Powder for Solution for Infusion (IV) Prescription Drug (RX) - Genzyme Polyclonal S.A.S. France Regular Renewal (Compliance) 30 March 2022 08 February 2026
View BR-307 Hepatitis B Immunoglobulin (Human) Hepabig 200 IU/mL Solution For Injection Prescription Drug (RX) Immunoglobulin Green Cross Corporation Korea Renewal 07 April 2022 22 March 2027